Skip to main content
Erschienen in: Gastric Cancer 1/2012

01.01.2012 | Original Article

Gastric linitis plastica: which role for surgical resection?

verfasst von: Corrado Pedrazzani, Daniele Marrelli, Fabio Pacelli, Maria Di Cosmo, Gianni Mura, Francesca Bettarini, Fausto Rosa, Giovanni de Manzoni, Franco Roviello

Erschienen in: Gastric Cancer | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

The role of surgery for gastric linitis plastica (GLP) is questioned. This study aimed to analyze our experience in the surgical treatment of GLP with specific reference to the resectability rate, prognosis, and mode of recurrence.

Methods

Results of surgery were analyzed in 102 patients with GLP.

Results

Of the 102 patients, 92 underwent surgical exploration, with resection performed in 60 cases. R2 resection was carried out in 20 patients and R1 in 12 patients, while the resection was considered potentially curative (R0) in 28 (27.5%). Overall, the median (95% confidence interval [CI]) survival time was 5.7 (3.7–7.5) months, with none of the patients alive at the end date of the study. For R0 patients the median (95% CI) survival time was 15.8 (11–20.7) months. The great majority of recurrences were intra-abdominal (peritoneal and/or locoregional), with a systemic component of the relapse that was rarely observed (5 cases).

Conclusions

After primary surgery, GLP showed a poor prognosis without regard to the extent or type of resection. The failure of surgical treatment related mainly to the peritoneal spread of the disease. Specifically designed multimodality treatment protocols should be tested in this setting.
Literatur
1.
Zurück zum Zitat Marrelli D, Pedrazzani C, Corso G, et al. Different pathological features and prognosis in gastric cancer patients coming from high-risk and low-risk areas of Italy. Ann Surg. 2009;250:43–50.PubMedCrossRef Marrelli D, Pedrazzani C, Corso G, et al. Different pathological features and prognosis in gastric cancer patients coming from high-risk and low-risk areas of Italy. Ann Surg. 2009;250:43–50.PubMedCrossRef
2.
Zurück zum Zitat Beyrouti MI, Beyrouti R, Ben Amar M, et al. Linitis plastica. Chirurgie. 2007;36:1782–6. Beyrouti MI, Beyrouti R, Ben Amar M, et al. Linitis plastica. Chirurgie. 2007;36:1782–6.
3.
Zurück zum Zitat Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965;64:31–49.PubMed Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965;64:31–49.PubMed
4.
Zurück zum Zitat Japanese Gastric Cancer Association (JGCA). The new Japanese classification of gastric carcinoma. 2nd English edition. Gastric Cancer. 1998;1:1–15. Japanese Gastric Cancer Association (JGCA). The new Japanese classification of gastric carcinoma. 2nd English edition. Gastric Cancer. 1998;1:1–15.
5.
Zurück zum Zitat American Joint Committee on Cancer. AJCC cancer staging atlas. New York: Springer Science+Business Media Inc.; 2006. American Joint Committee on Cancer. AJCC cancer staging atlas. New York: Springer Science+Business Media Inc.; 2006.
6.
Zurück zum Zitat Marrelli D, De Stefano A, de Manzoni G, Morgagni P, Di Leo A, Roviello F. Prediction of recurrence after radical surgery for gastric cancer: a scoring system obtained from a prospective multicenter study. Ann Surg. 2005;241:247–55.PubMedCrossRef Marrelli D, De Stefano A, de Manzoni G, Morgagni P, Di Leo A, Roviello F. Prediction of recurrence after radical surgery for gastric cancer: a scoring system obtained from a prospective multicenter study. Ann Surg. 2005;241:247–55.PubMedCrossRef
7.
Zurück zum Zitat Kodera Y, Nakanishi H, Ito S, et al. Detection of disseminated cancer cells in linitis plastica-type gastric carcinoma. Jpn J Clin Oncol. 2004;34:525–31.PubMedCrossRef Kodera Y, Nakanishi H, Ito S, et al. Detection of disseminated cancer cells in linitis plastica-type gastric carcinoma. Jpn J Clin Oncol. 2004;34:525–31.PubMedCrossRef
8.
Zurück zum Zitat Otsuji E, Kuriu Y, Okamoto K, et al. Outcome of surgical treatment for patients with scirrhous carcinoma of the stomach. Am J Surg. 2004;188:327–32.PubMedCrossRef Otsuji E, Kuriu Y, Okamoto K, et al. Outcome of surgical treatment for patients with scirrhous carcinoma of the stomach. Am J Surg. 2004;188:327–32.PubMedCrossRef
9.
Zurück zum Zitat Kodera Y, Yamamura Y, Ito S, et al. Is Borrmann type IV gastric carcinoma a surgical disease? An old problem revisited with reference to the result of peritoneal washing cytology. J Surg Oncol. 2001;78:175–81.PubMedCrossRef Kodera Y, Yamamura Y, Ito S, et al. Is Borrmann type IV gastric carcinoma a surgical disease? An old problem revisited with reference to the result of peritoneal washing cytology. J Surg Oncol. 2001;78:175–81.PubMedCrossRef
10.
Zurück zum Zitat Hamy A, Letessier E, Bizouarn P, et al. Study of survival and prognostic factors in patients undergoing resection for gastric linitis plastica: a review of 86 cases. Int Surg. 1999;84:337–43.PubMed Hamy A, Letessier E, Bizouarn P, et al. Study of survival and prognostic factors in patients undergoing resection for gastric linitis plastica: a review of 86 cases. Int Surg. 1999;84:337–43.PubMed
11.
Zurück zum Zitat Aranha GV, Georgen R. Gastric linitis plastica is not a surgical disease. Surgery. 1989;106:758–62.PubMed Aranha GV, Georgen R. Gastric linitis plastica is not a surgical disease. Surgery. 1989;106:758–62.PubMed
12.
Zurück zum Zitat Moreaux J, Barrat F, Msika S. Linitis plastica of stomach. Study of 102 cases surgically treated. Results of the surgical treatment. Chirurgie. 1986;112:485–92.PubMed Moreaux J, Barrat F, Msika S. Linitis plastica of stomach. Study of 102 cases surgically treated. Results of the surgical treatment. Chirurgie. 1986;112:485–92.PubMed
13.
Zurück zum Zitat Nakagawa S, Nashimoto A, Yabusaki H. Role of staging laparoscopy with peritoneal lavage cytology in the treatment of locally advanced gastric cancer. Gastric Cancer. 2007;10:29–34.PubMedCrossRef Nakagawa S, Nashimoto A, Yabusaki H. Role of staging laparoscopy with peritoneal lavage cytology in the treatment of locally advanced gastric cancer. Gastric Cancer. 2007;10:29–34.PubMedCrossRef
14.
Zurück zum Zitat de Graaf GW, Ayantunde AA, Parsons SL, Duffy JP, Welch NT. The role of staging laparoscopy in oesophagogastric cancers. Eur J Surg Oncol. 2007;33:988–92.PubMedCrossRef de Graaf GW, Ayantunde AA, Parsons SL, Duffy JP, Welch NT. The role of staging laparoscopy in oesophagogastric cancers. Eur J Surg Oncol. 2007;33:988–92.PubMedCrossRef
15.
Zurück zum Zitat de Manzoni G, Verlato G, Di Leo A, et al. Peritoneal cytology does not increase the prognostic information provided by TNM in gastric cancer. World J Surg. 2006;30:579–84.PubMedCrossRef de Manzoni G, Verlato G, Di Leo A, et al. Peritoneal cytology does not increase the prognostic information provided by TNM in gastric cancer. World J Surg. 2006;30:579–84.PubMedCrossRef
16.
Zurück zum Zitat Bentrem D, Wilton A, Mazumdar M, Brennan M, Coit D. The value of peritoneal cytology as a preoperative predictor in patients with gastric carcinoma undergoing a curative resection. Ann Surg Oncol. 2005;12:347–53.PubMedCrossRef Bentrem D, Wilton A, Mazumdar M, Brennan M, Coit D. The value of peritoneal cytology as a preoperative predictor in patients with gastric carcinoma undergoing a curative resection. Ann Surg Oncol. 2005;12:347–53.PubMedCrossRef
17.
Zurück zum Zitat Yan TD, Black D, Sugarbaker PH, et al. A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. Ann Surg Oncol. 2007;14:2702–13.PubMedCrossRef Yan TD, Black D, Sugarbaker PH, et al. A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. Ann Surg Oncol. 2007;14:2702–13.PubMedCrossRef
18.
Zurück zum Zitat Roviello F, Marrelli D, Neri A, et al. Treatment of peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion (IHCP): postoperative outcome and risk factors for morbidity. World J Surg. 2006;30:2033–40.PubMedCrossRef Roviello F, Marrelli D, Neri A, et al. Treatment of peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion (IHCP): postoperative outcome and risk factors for morbidity. World J Surg. 2006;30:2033–40.PubMedCrossRef
19.
Zurück zum Zitat Glehen O, Schreiber V, Cotte E, et al. Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer. Arch Surg. 2004;139:20–6.PubMedCrossRef Glehen O, Schreiber V, Cotte E, et al. Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer. Arch Surg. 2004;139:20–6.PubMedCrossRef
20.
Zurück zum Zitat Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355:11–20.PubMedCrossRef Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355:11–20.PubMedCrossRef
21.
Zurück zum Zitat Wu AW, Xu GW, Wang HY, Ji JF, Tang JL. Withdrawn: neoadjuvant chemotherapy versus none for resectable gastric cancer. Cochrane Database Syst Rev. 2007;4:CD005047. Wu AW, Xu GW, Wang HY, Ji JF, Tang JL. Withdrawn: neoadjuvant chemotherapy versus none for resectable gastric cancer. Cochrane Database Syst Rev. 2007;4:CD005047.
22.
Zurück zum Zitat Okabe H, Ueda S, Obama K, Hosogi H, Sakai Y. Induction chemotherapy with S-1 plus cisplatin followed by surgery for treatment of gastric cancer with peritoneal dissemination. Ann Surg Oncol. 2009;16:3227–36.PubMedCrossRef Okabe H, Ueda S, Obama K, Hosogi H, Sakai Y. Induction chemotherapy with S-1 plus cisplatin followed by surgery for treatment of gastric cancer with peritoneal dissemination. Ann Surg Oncol. 2009;16:3227–36.PubMedCrossRef
23.
Zurück zum Zitat Brigand C, Arvieux C, Gilly FN, Glehen O. Treatment of peritoneal carcinomatosis in gastric cancers. Dig Dis. 2004;22:366–73.PubMedCrossRef Brigand C, Arvieux C, Gilly FN, Glehen O. Treatment of peritoneal carcinomatosis in gastric cancers. Dig Dis. 2004;22:366–73.PubMedCrossRef
Metadaten
Titel
Gastric linitis plastica: which role for surgical resection?
verfasst von
Corrado Pedrazzani
Daniele Marrelli
Fabio Pacelli
Maria Di Cosmo
Gianni Mura
Francesca Bettarini
Fausto Rosa
Giovanni de Manzoni
Franco Roviello
Publikationsdatum
01.01.2012
Verlag
Springer Japan
Erschienen in
Gastric Cancer / Ausgabe 1/2012
Print ISSN: 1436-3291
Elektronische ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-011-0063-z

Weitere Artikel der Ausgabe 1/2012

Gastric Cancer 1/2012 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.